Two Doses of Recombinant Zoster Vaccine Worked Well in People 50 and Older – NEJM Journal Watch

  1. Two Doses of Recombinant Zoster Vaccine Worked Well in People 50 and Older  NEJM Journal Watch
  2. Study estimates 74% efficacy of shingles vaccine in patients over 50  CIDRAP
  3. Shingrix Vaccine Reduces Herpes Zoster Risk By 50% in Inflammatory Arthritis  Vaccine Advisor
  4. Why the Shingles Vax Is Important for Your Cardio Patients  Medscape

Continue Reading